Oramed Pharmaceuticals Inc (ORMP)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current ORMP market cap is 94.18M. The company's latest EPS is USD 0.1355 and P/E is 17.12.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 674k | 0 | 287k | 0 | 0 |
| Operating Income | -3.79M | -2.89M | -3.59M | -2.96M | -3.14M |
| Net Income | -1.19M | -3.22M | 13.34M | 1.54M | 9.21M |
| Year End December 30 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.71M | 2.7M | 904k | 2.7M | 1.63M |
| Operating Income | -11.76M | -24.22M | -12.33M | -40.6M | -15.77M |
| Net Income | -11.51M | -24.99M | -11.67M | -36.56M | 5.53M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 156.31M | 230.89M | 220.55M | 203.65M | 184.22M |
| Total Liabilities | 5.66M | 82.66M | 57.66M | 37.93M | 8.07M |
| Total Equity | 150.66M | 148.23M | 162.89M | 165.72M | 176.15M |
| Year End December 30 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 44.63M | 128M | 177.82M | 161.64M | 220.55M |
| Total Liabilities | 11.75M | 11.48M | 11.21M | 10.49M | 57.66M |
| Total Equity | 32.88M | 116.52M | 166.61M | 151.16M | 162.89M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.18M | -8.88M | -10.3M | -1.48M | 600k |
| Investing | -27.91M | -103.04M | -73.04M | 30M | 124.65M |
| Financing | 2.43M | 76.98M | 51.98M | -19M | -49.55M |
| Year End December 30 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.44M | -21.18M | -11.12M | -27.92M | -10.3M |
| Investing | 4.63M | -23.76M | -99.25M | 30.21M | -73.04M |
| Financing | 23.79M | 102.89M | 60.57M | 10.78M | 51.98M |
| Market Cap | 94.18M |
| Price to Earnings Ratio | 17.12 |
| Price to Sales Ratio | 58.15 |
| Price to Cash Ratio | 10.45 |
| Price to Book Ratio | 0.58 |
| Dividend Yield | - |
| Shares Outstanding | 40.77M |
| Average Volume (1 week) | 94.46k |
| Average Volume (1 Month) | 100.31k |
| 52 Week Change | -16.91% |
| 52 Week High | 3.67 |
| 52 Week Low | 1.67 |
| Spread (Intraday) | 0.16 (6.48%) |
| Company Name | Oramed Pharmaceuticals Inc |
| Address |
llc, 1013 center road jerusalem, jerusalem 19805 |
| Website | https://www.oramed.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
